83 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
in connection with any action, suit, proceeding or alternative dispute resolution mechanism, or hearing, inquiry or investigation that may lead
8-K
EX-10.1
ATHA
Athira Pharma Inc
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
communicating, cooperating, or participating in any investigation or proceeding that may be conducted by, any federal, state or local government agency … mean filing a charge, complaint, or report with, or otherwise communicating, cooperating, or participating in any investigation or proceeding that may
8-K
EX-10.1
73dp2rypqltm0js
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.3
ymedhqr
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-99.2
0ky25v
17 Oct 22
Results support potential clinically meaningful activity of fosgonimeton without background therapy and mitigate program risk
8:30am
8-K
EX-99.2
egs 47blb9
22 Jun 22
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
7:05am
DFAN14A
wqf4f8h
16 May 22
Additional proxy materials by non-management
2:04pm
DFAN14A
EX-99.1
eht1h m6kzun456e9
16 May 22
Additional proxy materials by non-management
2:04pm
DFAN14A
cq7sy
12 May 22
Additional proxy materials by non-management
2:06pm
DFAN14A
EX-99.1
1psxrm8
12 May 22
Additional proxy materials by non-management
2:06pm